Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed

News Daily News

Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed

December 01, 2017

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

News Conference News AHA 2017

Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation

Yael L. Maxwell

November 27, 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

November 14, 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

News Daily News

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

September 25, 2017

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

More Liberal Definition of Type 2 MI May Misclassify Some Patients

News Daily News

More Liberal Definition of Type 2 MI May Misclassify Some Patients

September 20, 2017

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

September 15, 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

News Conference News ESC 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

September 08, 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

News Conference News ESC 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Michael O'Riordan

August 26, 2017

Evolocumab Not Cost-Effective at Current List Price

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

Calcium Score Better Than Age for Discriminating Coronary Risk in Older Adults

News Daily News

Calcium Score Better Than Age for Discriminating Coronary Risk in Older Adults

July 27, 2017

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

News Daily News

Staying on Statins After an Adverse Event Lowers Risks of Death, MI or Stroke

Michael O'Riordan

July 25, 2017

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

News Daily News

CV Risk Higher With Modestly Elevated Troponin Levels, but Clinical Relevance Remains Unclear

July 24, 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

News Daily News

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Michael O'Riordan

May 30, 2017

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

News Daily News

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

May 15, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.